Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Barrett Business Services
BBSI
$784M
| $9.37M | 0.01% |
584,400
+20,800
| +4% | +$280K |
|
|
QIWI
1277
DELISTED
QIWI PLC
QIWI
| $9.33M | 0.01% |
730,500
+32,300
| +5% | +$428K |
|
|
CCC
1278
DELISTED
Calgon Carbon Corp
CCC
| $9.32M | 0.01% |
548,200
+78,300
| +17% | +$1.31M |
|
1279
Hain Celestial
HAIN
$52.5M
| $9.32M | 0.01% |
238,722
-423,500
| -64% | -$15.9M |
|
1280
Gen Digital
GEN
$17.2B
| $9.31M | 0.01% |
389,638
-2,712,400
| -87% | -$66.6M |
|
1281
Eaton
ETN
$176B
| $9.29M | 0.01% |
138,511
-461,200
| -77% | -$30.3M |
|
|
ACTA
1282
DELISTED
Actua Corp
ACTA
| $9.27M | 0.01% |
662,119
+110,100
| +20% | +$1.45M |
|
|
UN
1283
DELISTED
Unilever NV New York Registry Shares
UN
| $9.26M | 0.01% |
+224,558
| New | +$9.29M |
|
1284
Avis
CAR
$4.87B
| $9.24M | 0.01% |
251,980
+75,980
| +43% | +$2.75M |
|
1285
Park National Corp
PRK
$3.75B
| $9.24M | 0.01% |
77,226
+17,326
| +29% | +$1.85M |
|
1286
Hackett Group
HCKT
$270M
| $9.24M | 0.01% |
523,144
-69,900
| -12% | -$1.18M |
|
|
FONR
1287
DELISTED
Fonar
FONR
| $9.2M | 0.01% |
480,454
+20,638
| +4% | +$400K |
|
1288
Brown-Forman Class A
BF.A
$13.2B
| $9.18M | 0.01% |
248,125
-14,500
| -6% | -$555K |
|
1289
VanEck Gold Miners ETF
GDX
$27.5B
| $9.18M | 0.01% |
+438,800
| New | +$9.74M |
|
1290
Goldgroup Mining Inc.
GORO
$210M
| $9.17M | 0.01% |
2,107,700
+300,400
| +17% | +$1.48M |
|
1291
RLJ Lodging Trust
RLJ
$1.69B
| $9.17M | 0.01% |
+374,300
| New | +$8.25M |
|
1292
ServiceNow
NOW
$129B
| $9.16M | 0.01% |
+616,000
| New | +$9.94M |
|
|
HCOM
1293
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
| $9.13M | 0.01% |
368,600
+18,600
| +5% | +$423K |
|
1294
Evolution Petroleum
EPM
$132M
| $9.13M | 0.01% |
913,200
+158,700
| +21% | +$1.33M |
|
1295
Vanda Pharmaceuticals
VNDA
$313M
| $9.06M | 0.01% |
568,350
+136,300
| +32% | +$2.19M |
|
|
STOR
1296
DELISTED
STORE Capital Corporation
STOR
| $9.05M | 0.01% |
366,200
+39,900
| +12% | +$1.03M |
|
|
LMOS
1297
DELISTED
Lumos Networks Corp
LMOS
| $9.04M | 0.01% |
578,500
+117,200
| +25% | +$1.71M |
|
|
SVA
1298
DELISTED
Sinovac Biotech, Ltd
SVA
| $9M | 0.01% |
1,524,800
+49,800
| +3% | +$300K |
|
|
FGL
1299
DELISTED
Fidelity & Guaranty Life
FGL
| $8.99M | 0.01% |
379,500
+179,800
| +90% | +$4.18M |
|
1300
MYR Group
MYRG
$5.21B
| $8.97M | 0.01% |
238,200
+34,000
| +17% | +$1.17M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.